PLN 122.5
(-2.78%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 424.18 Million PLN | 2.26% |
2022 | 414.8 Million PLN | -6.29% |
2021 | 442.66 Million PLN | 35.11% |
2020 | 327.64 Million PLN | 54.8% |
2019 | 211.66 Million PLN | 24.21% |
2018 | 170.41 Million PLN | 11.99% |
2017 | 152.15 Million PLN | 26.1% |
2016 | 120.66 Million PLN | -8.62% |
2015 | 132.04 Million PLN | 28.3% |
2014 | 102.92 Million PLN | -0.29% |
2013 | 103.21 Million PLN | 78.83% |
2012 | 57.71 Million PLN | -40.62% |
2011 | 97.2 Million PLN | 58.13% |
2010 | 61.46 Million PLN | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 108.63 Million PLN | 10.22% |
2024 Q2 | 123.94 Million PLN | 14.09% |
2023 Q3 | 127.93 Million PLN | 26.8% |
2023 Q1 | 96.78 Million PLN | -30.93% |
2023 FY | 424.18 Million PLN | 2.26% |
2023 Q4 | 98.56 Million PLN | -22.96% |
2023 Q2 | 100.89 Million PLN | 4.24% |
2022 Q3 | 98.64 Million PLN | 29.59% |
2022 FY | 414.8 Million PLN | -6.29% |
2022 Q1 | 99.91 Million PLN | -22.72% |
2022 Q2 | 76.11 Million PLN | -23.82% |
2022 Q4 | 140.12 Million PLN | 42.05% |
2021 FY | 442.66 Million PLN | 35.11% |
2021 Q1 | 111.71 Million PLN | -18.99% |
2021 Q2 | 107.91 Million PLN | -3.4% |
2021 Q3 | 93.73 Million PLN | -13.14% |
2021 Q4 | 129.29 Million PLN | 37.94% |
2020 Q4 | 137.9 Million PLN | 59.01% |
2020 FY | 327.64 Million PLN | 54.8% |
2020 Q3 | 86.72 Million PLN | 64.91% |
2020 Q2 | 52.58 Million PLN | 4.3% |
2020 Q1 | 50.42 Million PLN | -25.11% |
2019 Q4 | 67.32 Million PLN | 38.44% |
2019 Q3 | 48.63 Million PLN | 4.35% |
2019 Q2 | 46.6 Million PLN | -5.06% |
2019 Q1 | 49.09 Million PLN | -25.14% |
2019 FY | 211.66 Million PLN | 24.21% |
2018 FY | 170.41 Million PLN | 11.99% |
2018 Q2 | 33.75 Million PLN | 3.66% |
2018 Q4 | 65.57 Million PLN | 70.25% |
2018 Q3 | 38.51 Million PLN | 14.12% |
2018 Q1 | 32.56 Million PLN | -41.54% |
2017 Q4 | 55.69 Million PLN | 70.28% |
2017 Q3 | 32.7 Million PLN | 9.63% |
2017 FY | 152.15 Million PLN | 26.1% |
2017 Q1 | 33.92 Million PLN | -7.55% |
2017 Q2 | 29.83 Million PLN | -12.05% |
2016 Q3 | 24.48 Million PLN | -20.55% |
2016 Q2 | 30.81 Million PLN | 7.48% |
2016 Q4 | 36.69 Million PLN | 49.87% |
2016 FY | 120.66 Million PLN | -8.62% |
2016 Q1 | 28.67 Million PLN | -36.42% |
2015 Q4 | 45.09 Million PLN | 48.29% |
2015 Q1 | 25.95 Million PLN | -22.64% |
2015 Q2 | 30.59 Million PLN | 17.9% |
2015 Q3 | 30.4 Million PLN | -0.61% |
2015 FY | 132.04 Million PLN | 28.3% |
2014 Q3 | 25.24 Million PLN | 11.08% |
2014 FY | 102.92 Million PLN | -0.29% |
2014 Q4 | 33.54 Million PLN | 32.85% |
2014 Q2 | 22.73 Million PLN | 6.23% |
2014 Q1 | 21.39 Million PLN | -16.75% |
2013 Q2 | 25.3 Million PLN | 31.15% |
2013 Q4 | 25.7 Million PLN | -21.91% |
2013 Q3 | 32.91 Million PLN | 30.07% |
2013 FY | 103.21 Million PLN | 78.83% |
2013 Q1 | 19.29 Million PLN | 316.7% |
2012 Q4 | -8.9 Million PLN | -144.11% |
2012 Q1 | 22.31 Million PLN | -36.13% |
2012 Q2 | 23.84 Million PLN | 6.84% |
2012 Q3 | 20.18 Million PLN | -15.34% |
2012 FY | 57.71 Million PLN | -40.62% |
2011 Q3 | 20.01 Million PLN | 0.0% |
2011 FY | 97.2 Million PLN | 58.13% |
2011 Q4 | 34.94 Million PLN | 74.62% |
2010 FY | 61.46 Million PLN | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
BioMaxima S.A. | 46.78 Million PLN | -806.644% |
Scope Fluidics S.A. | 516 Thousand PLN | -82105.891% |
Selvita S.A. | 346.95 Million PLN | -22.258% |